Currently predicting for Wed, 1 May 2024

Trading levels for LABP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.59 1.32 %
R2 22.49 0.84 %
R1 22.42 0.539 %
Current price: 22.30
Support S1 22.21 -0.420 %
S2 22.14 -0.716 %
S3 22.03 -1.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 22.49 0.85 %
R2 22.48 0.81 %
R1 22.31 0.0448 %
Current price 22.30
Support S1 21.56 -3.32%
S2 21.50 -3.59%
S3 21.40 -4.04%

LABP Predictions History

2 years ago
JS predicted that LABP for 2022-01-05 is going $5.11 (13.56%)

2 years ago
irawesome99.234992 predicted that LABP for 2022-01-05 is going

Rank:

2 years ago
JS predicted that LABP for 2021-10-29 is going $13.65 (1.41%)

2 years ago
codyfinancial28.262438 predicted that LABP for 2021-10-29 is going

Rank:

3 years ago
JS predicted that LABP for 2021-03-01 is going $13.63 (-16.17%)

3 years ago
katedobrin.217046 predicted that LABP for 2021-03-01 is going $13.48 (0.00%)

Rank:
Click to get the best stock tips daily for free!

About Landos Biopharma, Inc.

Landos Biopharma. Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted ora... LABP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT